TG Therapeutics, Inc. is a company that provides Ublituximab, Monoclonal antibody, Medicine and more. TG Therapeutics, Inc. is headquartered in United States New York. TG Therapeutics, Inc. was founded in 1993. TG Therapeutics, Inc. has a total of 69 patents and 5 literature
TG Therapeutics is an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important...